跳转至内容
Merck
CN

KZRVA10TT1

Opticap XL10 Viresolve NFR 1-1/2 in.TC/TC

Retrovirus removal

别名:

Opticap® XL Viresolve® NFR过滤器

登录 查看组织和合同定价。

选择尺寸

关于此项目

eCl@ss:
32031690
UNSPSC Code:
23151806

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Opticap XL10 Viresolve NFR 1-1/2 in.TC/TC, Retrovirus removal

material

polyethersulfone
polypropylene
polypropylene support
polypropylene vent cap
silicone seal

feature

holdup volume 175 mL

manufacturer/tradename

Viresolve®

parameter

≤16 mL/min air diffusion at 3.45 bar (50 psig) and 23 °C (in water)
25 °C max. inlet temp.
3.4 bar max. differential pressure (50 psid) (Reverse)
5.5 bar max. differential pressure (80 psid) (Forward)
600-1200 L process volume
80 psig max. inlet pressure

technique(s)

protein purification: suitable

L

33 cm (13 in.)

device size

10 in.

filtration area

0.43 m2

inlet connection diam.

1.5 in.

outlet connection diam.

1.5 in.

impurities

≤0.5 EU/mL bacterial endotoxins (LAL test, Aqueous extraction)
<0.5 EU/mL USP bacterial endotoxins (LAL test, sample aqueous extraction)

gravimetric extractables

≤35 mg

matrix

Viresolve® NFR

fitting

1/4 in. drain/vent hose barb (with double O-ring Seal)
 inlet sanitary flange
38 mm (1 1/2 in.) inlet/outlet sanitary flange
 outlet sanitary flange

Quality Level

400

Analysis Note

Gravimetric Extractables: after a 10 minute 1.5 LPM/ft² flush and 24 hours in water at controlled room temperature
Will meet the USP Oxidizable Substances Test requirements after a water flush of ≥4 L

General description

Device Configuration: 取样皿滤膜

Application

Retrovirus removal

Disclaimer

EMD Millipore Corporation certifies that this product complies with the European Pressure Equipment Directive, 97/23/EC of 29 May 1997. This product has been classified under Article 3 § 3 of the Pressure Vessel Directive. It has been designed and manufactured in accordance with sound engineering practice to ensure safe use. In compliance with Article 3 § 3 of this Pressure Vessel Directive, this product does not bear the CE mark.

Other Notes

Directions for Use

  • Organism Retention: Retrovirus
  • Mode of Action: Filtration (size exclusion)
  • Application: Protein purification
  • Intended Use: Viral clearance
  • Instructions for Use: Please see the user guide (pg. 3) shipped with this product
  • Storage Statement: Store at room temperature
  • Disposal Statement: Dispose of in accordance with applicable federal, state and local regulations.

These products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.

Packaging

Double Easy-Open bag

Preparation Note

Sterilization Method
After wetting, may be autoclaved for 3 cycles of up to 60 min at 125 °C, using liquid cycle, slow exhaust.
This product was manufactured with a Viresolve® membrane which meets the criteria for a "non-fiber releasing" filter as defined in 21 CFR 210.3 (b) (6).

Legal Information

OPTICAP is a registered trademark of Merck KGaA, Darmstadt, Germany
VIRESOLVE is a registered trademark of Merck KGaA, Darmstadt, Germany

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持